Clariant AG (CLZNY)

Clariant AG is a Swiss specialty chemicals company whose common stock is represented in the U.S. through this ADR listing on OTC Markets. The company develops, manufactures, distributes, and sells specialty chemical products across Switzerland, Europe, the Middle East, Africa, the United States, and Asia Pacific. Its operations are organized into three segments: Care Chemicals, Catalysts, and Adsorbents & Additives. Care Chemicals covers applications used in personal and home care, crop solutions, industrial uses, base chemicals, oil services, and mining. Catalysts focuses on propylene and ethylene, syngas and fuels, and specialty applications. Adsorbents & Additives supplies solutions used in coatings, adhesives, polymers, agriculture, food, electronics, automotive, building and construction, aviation, oil, and mining. Founded in 1886, Clariant is headquartered in Muttenz, Switzerland.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-CLZN.Y
$13.60
40.2% Upside
Undervalued
Good
0.46
0.0%
July 31, 2026
-31.5x
1.2x
0.6x
2.925 B
4.358 B
44.7%
59.2%
7.9
-184.0%
-365.3%
Valuation • Fair Value

Clariant AG (OTC-CLZN.Y) Fair Value by Valuation Model

Compare the primary fair value estimate for Clariant AG (OTC-CLZN.Y) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$13.60

Estimated upside of 40.2% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$17.21

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

$9.52

Dividend discount model valuation reference.

EPV Fair Value

$11.32

Earnings power value estimate.

Comps Fair Value

$11.73

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Clariant AG (OTC-CLZN.Y) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Clariant AG (OTC-CLZN.Y)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

4.942 B

Current operating scale indicator.

Revenue Forecast

4.674 B

Forward revenue estimate.

EBITDA

743.5 M

Current operating profitability reference.

EBITDA Forecast

815.1 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Clariant AG (OTC-CLZN.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Clariant AG (OTC-CLZN.Y)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-3.00

No elevated caution signal from this screen.

Altman Z-Score

7.9

Relatively strong balance-sheet zone.

FCF / Net Income

-365.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Clariant AG (OTC-CLZN.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Clariant AG (OTC-CLZN.Y)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 31, 2026

Days to Earnings

10

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

0.46

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

-184.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Clariant AG (OTC-CLZN.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Clariant AG (OTC-CLZN.Y) Stock Forecast & Technical Outlook

Review Clariant AG (OTC-CLZN.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Clariant AG (OTC-CLZN.Y) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Clariant AG (OTC-CLZN.Y) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Clariant AG (OTC-CLZN.Y) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Clariant AG (OTC-CLZN.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Clariant AG (OTC-CLZN.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Clariant AG (OTC-CLZN.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Clariant AG (OTC-CLZN.Y) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

Clariant AG (OTC-CLZN.Y) Stock FAQ

Quick answers about Clariant AG (OTC-CLZN.Y) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$13.60
Estimated upside 40.2%
Valuation Rating
Undervalued
Estimated upside of 40.2%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Good
Current financial-health read

The current fair value estimate for Clariant AG (OTC-CLZN.Y) is $13.60. This implies an estimated upside of 40.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 40.2% versus the current market price.

An analyst price target for Clariant AG (OTC-CLZN.Y) is not currently available in the latest data file.

The current financial health read for Clariant AG (OTC-CLZN.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Clariant AG (OTC-CLZN.Y) is July 31, 2026.

Based on the current data, dividend yield is 0.0%, upcoming dividend amount is 0.46.

The current P/E ratio listed for Clariant AG (OTC-CLZN.Y) is -31.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Clariant AG is 2.925 B.

The current enterprise value listed for Clariant AG is 4.358 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Clariant AG is OTC-CLZN.Y, and the stock is listed on OTC Markets.

Clariant AG (OTC-CLZN.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Clariant AG is 44.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Clariant AG is 59.2%. Free float helps investors understand how much of the share base is available for public trading.